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Abstract: We present ProtaBank, a repository for storing, querying, analyzing, and sharing protein
design and engineering data in an actively maintained and updated database. ProtaBank provides
a format to describe and compare all types of protein mutational data, spanning a wide range of
properties and techniques. It features a user-friendly web interface and programming layer that
streamlines data deposition and allows for batch input and queries. The database schema design
incorporates a standard format for reporting protein sequences and experimental data that facili-
tates comparison of results across different data sets. A suite of analysis and visualization tools
are provided to facilitate discovery, to guide future designs, and to benchmark and train new pre-
dictive tools and algorithms. ProtaBank will provide a valuable resource to the protein engineering
community by storing and safeguarding newly generated data, allowing for fast searching and
identification of relevant data from the existing literature, and exploring correlations between dis-
parate data sets. ProtaBank invites researchers to contribute data to the database to make it
accessible for search and analysis. ProtaBank is available at https://protabank.org.
Abbreviations: 3D, three-dimensional; API, application programming interface; AWS, Amazon Web Services; BLAST, Basic Local
Alignment Search Tool; Cm, concentration of denaturant at midpoint of unfolding transition; CSV, comma-separated values;
DG, Gibbs free energy of folding/unfolding; Gb1, b1 domain of Streptococcal protein G; GdmCl, guanidinium chloride; kcat,
catalytic rate constant; Kd, dissociation constant; MIC, minimum inhibitory concentration; PDB, Protein Data Bank; PE, protein
engineering; RDS, Relational Database Services; REST, Representation State Transfer; Tm, melting temperature
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Impact: The ProtaBank database provides a central repository for researchers to store, query, analyze, and share all types of protein engi-
neering data. This modern database will serve a pivotal role in organizing protein engineering data and leveraging the increasingly large
amounts of mutational data being generated. Together with the analysis tools, it will help scientists gain insights into sequence-function
relationships, support the development of new predictive tools and algorithms, and facilitate future protein engineering efforts.
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Introduction
Recent advances in gene synthesis, microfluidics,
deep sequencing, and microarray techniques have
greatly facilitated the ability of researchers to con-
struct and assess large libraries of variant protein
sequences.1–4 Thousands or even millions of
sequence variants can now be generated and
screened in an ultrahigh-throughput fashion. This
rapid generation of large sets of mutational data has
enabled comprehensive mappings between protein
sequence and function for properties such as stabil-
ity, binding affinity, and catalytic activity.5–7 Deep
mutational scanning approaches have been used to
study protein fitness landscapes, discover new func-
tional sites, and engineer proteins with new and
improved properties.8,9 Many groups are now using
these techniques to generate large amounts of pro-
tein engineering (PE) data—a trend that is expected
to grow in the future.
The field of PE thus appears to be entering into
a state reminiscent of the early days of widespread
structure determination and genome sequencing.
The Protein Data Bank10,11 (PDB) (www.rcsb.org)
and GenBank12 were created because scientists rec-
ognized the importance of organizing the vast num-
ber of protein structures and nucleic acid sequences
into databases with standardized formats. Since
their inception, these open-access databases have
grown exponentially and have proven to be
extremely valuable resources for the scientific com-
munity. A similar situation now exists with the
rapid expansion in PE data. Unfortunately, there is
no central repository to store all the PE data being
generated, no standardized format for describing it,
and no simple means of sharing the data with
collaborators.
Here, we present ProtaBank, a database for
storing, querying, analyzing, and sharing PE data.
This type of information (mutant protein sequences
and their associated experimental assay data) is not
stored in GenBank or the PDB, and although other
databases store some of the data types included in
ProtaBank, they are not designed for all types of PE
data or have limited tools for inclusion of large
amounts of mutant information. Of these, the best
known are ProTherm13 (thermodynamic database
for wild-type and mutant proteins), UniProt14 (pro-
tein sequences with annotations), and BRENDA15
(enzymes and metabolic information). ProTherm is
limited to thermodynamic protein stability data and
has not been updated since 2013. UniProt and
BRENDA were not designed for PE data, and
although some mutant data is included, storage and
retrieval is limited. The Protein Mutant Database16
includes PE data on a broad range of protein proper-
ties, but has not been updated in over a decade.
Recently, a number of mutant databases were devel-
oped to facilitate the study of protein–protein interac-
tions. These include SKEMPI17 and PROXiMATE,18
which contain thermodynamic data for mutant pro-
tein–protein complexes, and AB-Bind,19 which focuses
on binding data for a select set of antibody–antigen
complexes. Overall, the mutational data that is avail-
able tends to be scattered across many different spe-
cialized databases.
ProtaBank provides a single repository for all
types of PE data, spanning a wide range of proper-
ties, including those related to activity, binding, sta-
bility, folding, and solubility. The database
accommodates mutational data obtained from
diverse approaches, including computational and
other types of rational design, saturation mutagene-
sis, directed evolution, and deep mutational scan-
ning. Unlike many other mutant databases,
ProtaBank stores the entire protein sequence for
each of the variants instead of just the mutations
and provides detailed descriptions of the experimen-
tal assays used. These features are incorporated to
allow for accurate comparisons of measurements
across multiple studies or groups, making it easier
to identify trends and determine how different
assays, parameters, or conditions affect the results.
We stress the importance of a standardized for-
mat for reporting PE data that allows accurate com-
parisons between different data sets, and anticipate
that the ProtaBank format will become an industry-
wide standard used by the entire PE community.
This will facilitate sharing PE data with collabora-
tors and will improve the usability of PE datasets
for data mining and other analysis methods. The
ProtaBank database, together with its analysis and
visualization tools, will help scientists gain insights
into sequence-activity and structure-activity rela-
tionships, improve our understanding of how pro-
teins function, and ultimately facilitate the design of
proteins with new and improved properties. The
database should also accelerate the development of
new predictive tools and algorithms, and lead to
improved methods for computational protein design
and engineering.
Database Construction and Content
Overview
ProtaBank has three main components: (1) a web
interface and application programming interface
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(API) for data deposition, (2) a back-end relational
database for data storage, and (3) a web interface
and API for data searching and analysis. The design
and workflow for ProtaBank is summarized in Fig-
ure 1. Users can submit data into the database
through the web interface; access to external data-
bases such as PubMed,20 the PDB, and UniProt are
provided to facilitate the entry of publication infor-
mation, structural data, and sequence data. In addi-
tion, a Representation State Transfer (REST) API
layer is provided for batch submission of data. All
data undergoes validation and curation before final
submission into the database. One can use the web
interface or the REST API to search and filter stud-
ies and data based on PubMed ID, PDB ID, UniProt
accession number, protein name, protein sequence,
assay, or publication information. More advanced
analysis and comparison tools are also available via
the web interface. For example, users can do a
sequence search with the Basic Local Alignment
Search Tool (BLAST)21 and use visualization tools to
map mutational data onto a PDB structure.
Database schema
ProtaBank is implemented as a relational database
using the PostgreSQL database. The highest level of
organization is a study corresponding to a PE effort.
Each study has four core tables to describe the PE
data: sequence_complex, assay_expassay, data_expf-
datum, and data_units which, respectively, represent
the sequence of a given protein mutant, the experi-
mental assay that was used to probe the property of
interest, the numerical value obtained for the
mutant (i.e., the assay results), and the units associ-
ated with the numerical value (Fig. 2). ProtaBank
also has separate corresponding tables to represent
computational protocols and derived quantities, and
to store qualitative data (e.g., folded/unfolded) or
data expressed in terms of a range or limit (e.g., 20–
30, >100). In addition to the core data tables, each
study includes publication information, structural
data on the protein that was engineered (i.e., the
PDB file, if available), and experimental gene con-
struct information. This information adds context
and additional query and filter parameters to the
PE data. Non-published PE studies can also be input
in a similar fashion. In these cases, the researchers
and organizations involved are specified instead of
the authors and affiliations. Depositors of non-
published results may embargo the release of the
data until publication.
The ProtaBank schema design incorporates two
crucial elements: (1) the full amino acid sequence of
the protein is stored to facilitate comparison of
mutants across different assays and studies, and (2)
for each assay, information about the protein prop-
erty measured, the assay conditions and techniques
used, and the units of the resulting data is collected
in addition to the results. Although these require-
ments necessitate more upfront effort in deposition
and curation, we believe they are necessary to
enable useful comparisons of results across different
studies. Our reasoning is as follows.
First, PE studies and databases13,16 typically
describe a mutant by listing the changes to its pro-
tein sequence relative to a specified starting
sequence. However, the starting sequences used in
engineering a given protein are often not the same
across studies, which can cause confusion and makes
comparisons challenging. The wild-type protein is
not always used; residues may be changed, added,
or deleted at the termini, for example, to facilitate
expression or purification, or substitutions may be
made to make the protein more amenable to the
assay conditions. Many mutant databases only store
the mutational data for the positions mutated. For
Figure 1. ProtaBank design. Users can interact with ProtaBank through the web interface or the REST API. Data sent to the
server is validated and curated before final submission into the database. AWS, Amazon Web Services; RDS, Relational Data-
base Services.
Wang et al. PROTEIN SCIENCE VOL 27:1113—1124 1115
example, M3A1V5L1S19T might be used to iden-
tify a mutant that has been mutated to Ala, Leu,
and Thr at positions 3, 5, and 19, respectively; the
rest of the sequence (the background in which the
mutations were made) is either not given or not
recorded. Not knowing the entire sequence for each
mutant confounds comparisons, as any differences in
the reported results could be due to differences in
the background residues. ProtaBank addresses this
issue by providing web forms and an API that
parses the input mutant information to return the
full sequence so it can be stored as such, allowing
for a straightforward comparison of mutants across
studies. This feature also makes it possible to vali-
date the accuracy of mutant data provided in the
WT#MUT (wild-type amino acid, residue #, mutant
amino acid) format; that is, the wild-type amino acid
listed for each of the mutated positions is compared
to what is specified in the starting sequence, and
any discrepancies are flagged.
Second, comparison across studies may be diffi-
cult due to differences in assay conditions or techni-
ques, which can greatly affect the results.22–24 The
ProtaBank schema takes these issues into account.
As outlined above, the database uses the
assay_expassay table to describe the procedure that
was used to determine a given protein property.
This table has foreign key relationships with a
series of other tables (category, property, technique,
units) that help categorize and describe the many
ways these properties can be measured. The cate-
gory table provides the general type of protein prop-
erty that was engineered or studied (e.g., stability,
activity, binding). The property table is more specific
and describes the property that was actually mea-
sured and gave rise to the result [e.g., melting tem-
perature (Tm), catalytic rate constant (kcat),
dissociation constant (Kd)]. The categories and prop-
erties currently included in ProtaBank are listed in
Supporting Information Table S1. Commonly used
experimental or computational techniques are also
provided to indicate how the property was assayed
(e.g., circular dichroism, surface plasmon resonance).
Note that the properties and techniques supplied
are not comprehensive, and users can enter addi-
tional ones. Finally, the units table contains com-
monly used units that are appropriate to the
property measured. For example, the units available
for the Gibbs free energy of folding/unfolding (DG)
are kcal/mol and kJ/mol. This level of description is
Figure 2. ProtaBank database schema showing the table for experimental data represented by a number (data_expfdatum,
blue header) and all tables with foreign key relationships to it. Each table shows the field name (left) and the variable type for
the field (right). Each datum in the data_expfdatum table has a foreign key relationship (orange arrow) to a study table (study_-
study) that organizes the context in which the experiments were performed, an assay table (assay_expassay) that describes the
procedure used to obtain the measurement, a sequence table (sequence_complex) that holds the protein sequence of the
mutant, and a units table (data_unit) that describes the units of the result. For data that is part of a mutant library, a foreign key
links it to the library table (data_libexpfdatum). Analogous tables exist for data obtained from computations/simulations, derived
data, and qualitative or range data. uuid, universally unique ID; avail_date, date study is available for public; seqstr, sequence
string; temp, temperature; prot_conc, protein concentration; timestamptz, time stamp with time zone; varchar, variable charac-
ter; bool, boolean; int, integer; float, floating point number; fk, foreign key.
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designed to provide enough detail so that data col-
lected from different sources can be compared and
analyzed appropriately.
Data deposition and curation
ProtaBank will serve as a curated and continuously
updated repository for PE studies. Thus far, data in
ProtaBank has come directly from the published lit-
erature and has been manually entered by Prota-
Bank developers. To aid in the future data collection
process, ProtaBank is designed to accept data input
directly from the researchers who performed the
study, a strategy that has proved effective in popu-
lating other biological databases such as the PDB,
GenBank, ArrayExpress,25 and WormBase.26 Any
user can input a study via the ProtaBank data sub-
mission tools. Two modes of data deposition are pro-
vided: an interactive web interface that supports
upload of data in a spreadsheet format [i.e., via a
comma-separated values (CSV) file] (see Supporting
Information Fig. S1), and a REST API layer that
allows for programmatic batch upload of data (see
https://protabank.org/docs for details).
ProtaBank data deposition tools are designed to
accept the wide range of data generated in PE
efforts and to automate the process so as to facilitate
entry and ensure accuracy. Publication details (e.g.,
authors, title, journal, date, abstract) can be fetched
from PubMed, and the protein sequence can be
retrieved from the PDB or UniProt. If available,
structural data for the protein can be fetched from
the PDB.
The database schema requires a description of
the methods used to assay the protein mutants. For
each assay, one must specify an assay name, the
general category of protein property that was engi-
neered or studied, the specific property measured,
the technique employed, and the units used. All
items except the assay name are specified by select-
ing from options in a drop-down menu. Additional
details can be included if desired. By entering this
information, assays can be clearly defined and
compared.
PE data can be input in two forms: as individual
sequences or as a mutant library (a set of mutant
sequences obtained by mutating a specified set of
residues in a protein). Mutational data can be
uploaded from a CSV file or it can be entered manu-
ally on the web form. The data entry page for a
mutant library is shown in Supporting Information
Fig. S1. To specify a mutant library, the user must
first enter the starting protein sequence from which
the mutations were made. All mutants in the library
can then be described either by their full sequence
or as mutations from this starting sequence. Two
formats are allowed for the latter: (1) the WT#MUT
format (e.g., M3A1V5L1S19T) and (2) the mutated
residue range/list format in which a range or list of
residues is specified that correlates positions in the
starting sequence with the amino acids given in the
CSV file (e.g., QRS for residues 3–5; or QRS for resi-
dues 3, 5, 7). ProtaBank then takes the description
of mutants entered, parses the data, and stores it as
full amino acid sequences.
All submitted data is validated to ensure data
integrity before inclusion in the database. Auto-
mated tests are first performed to ensure that: (1)
the data falls within the correct range of values
(e.g., temperature in K must be a non-negative num-
ber), (2) the assigned units are appropriate for the
assayed property, and (3) the amino acid listed for
wild type is consistent with that specified in the
starting sequence (for mutants described in the
WT#MUT format). Outliers in a data set are also
flagged and the submitter is asked to check for accu-
racy. Currently, ProtaBank developers also check
studies manually for sequence and data accuracy,
appropriate specification of protein properties, and
proper description of assays. Potential errors are
sent back to the submitter for review.
Search and analysis tools
ProtaBank provides several search and analysis
tools that allow users to: (1) browse and search for
relevant studies queried by publication/study details
(title, abstract, author), protein name, PDB ID, Uni-
Prot accession number, or protein sequence, (2) iden-
tify data and mutants related to a given protein
sequence by BLAST search, (3) visualize mutational
data mapped onto a three-dimensional (3D) protein
structure, and (4) compare and correlate data mea-
sured using different assays. Figure 3(A) shows a
screenshot of the web interface in which the “Browse
all submitted studies” tool was used to filter studies
by protein name (“ubiquitin”). Figure 3(B) shows a
screenshot in which study analysis tools were used
to visualize mutational data on a 3D protein struc-
ture. The visualizer is based on PV, an open-source
javascript protein viewer (https://biasmv.github.io/
pv/index.html) that was extended to allow mutations
to be represented on the 3D structure using differ-
ent color schemes. These include coloring by second-
ary structure, gradient, minimum, maximum,
median, mean, proportion above a reference value,
and median deviation from a reference value. In the
study depicted here, Jacquier et al. investigated the
effects of mutations on TEM-1 b-lactamase activity
by computing the amoxicillin minimum inhibitory
concentration (MIC) score for 990 point mutants.27
Figure 3(B) shows the crystal structure of TEM-1
(PDB ID: 1BTL)28 displayed with the backbone col-
ored by the MIC score. In this case, the median devi-
ation from the wild-type value is shown, with
residues colored from red to white to blue depending
on whether the value is less (red) or greater (blue)
than the wild-type value at that position, with white
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representing an equal value. Pointing the cursor at
a residue (e.g., Leu57) highlights it in yellow and
displays additional information for that residue in
the tables below and to the right.
Utility and Discussion
The following case studies demonstrate how Prota-
Bank search and analysis tools can aid in analyzing
and interpreting PE data.
Case study 1: Identify and compare data for a
protein sequence
Before beginning any PE study, a review of existing
literature on the protein of interest provides a useful
reference point. Therefore, a simple but important
application of ProtaBank is to identify and compare
previously measured properties of a given sequence.
Because ProtaBank stores the full sequence informa-
tion for each mutant, a simple query on a specified
protein sequence retrieves all the relevant data for
Figure 3. Screenshots of the web interface when using ProtaBank search and analysis tools. (A) A text-based search for
“ubiquitin” returns a sortable table containing all studies with ubiquitin in the protein name or study title. Clicking on the study
ID at the left brings up the analysis page for that study. (B) The analysis page for a study on b-lactamase27 includes a protein
visualizer in which mutational results are mapped onto the protein structure according to the selected color scheme. Here,
Leu57 is highlighted in yellow and the single mutant data for that residue is displayed in the tables below and to the right. We
see that Leu57 was mutated to His, Ile, and Pro, resulting in scores of 21.66, 0.25, and 25.32, respectively (mean522.24);
residue values are colored from red to white to blue depending on whether they are less than (red) or greater than (blue) the
value of the reference at that position (white).
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that sequence, even if the starting sequences were
different. In this case study, we use ProtaBank’s
“Compare data for a sequence” tool to search for
data on the wild-type sequence of the b1 domain of
Streptococcal protein G (Gb1): MTYKLILNGKTLK-
GETT TEAVDAATAEKVFKQYANDNGVDGEWTYD-
DATKT FTVTE. ProtaBank returns a sortable and
searchable table listing all the data for the specified
search sequence, including all the properties, assays,
results, units, and titles of the associated studies. We
can then search this data table for “Gibbs free ener-
gy” to just show the data in which DGs were mea-
sured. The DG search shows five experimentally
measured values for DG of unfolding (DGu) from five
studies,29–33 with values differing by up to 1.8 kcal/
mol.
These differences could represent statistical var-
iation in the measurement of this property. However,
differences in assay techniques or conditions could
also be responsible. ProtaBank provides links in the
data table so that you can quickly view the details
for each assay. A careful examination of assay
details shows that an important difference between
the assays was the pH used for denaturation; the
temperature was 258C for all the measurements
except one (see Table I). Different techniques were
also used (chemical vs. thermal denaturation), but
these gave similar results when the temperature
and pH were similar. These results suggest that the
pH and/or temperature can have a notable effect on
DGu. Thus, in order to make meaningful compari-
sons of engineered mutants relative to the wild type,
it is clearly important to select the results with the
most closely matched experimental conditions. We
expect that by facilitating these types of compari-
sons, ProtaBank will provide context for the results
in each study, reveal assay parameters that can
impact the results, and enable an informed evalua-
tion of results obtained under different assay
conditions.
For theoretical and computational scientists,
ProtaBank provides another valuable service—easy
access to data sets that can be used to benchmark,
test, and improve predictive methods. For example,
the experimental results provided in this case study
could be used to test theoretical methods aimed at
predicting the effect of pH and/or temperature on a
protein’s stability based on how many ionizable side
chains it contains.34,35
Case study 2: Identify and analyze data for
closely related mutants of a protein sequence
Protein engineers are typically not only interested
in the data reported for a given sequence, but in the
data reported for closely related sequences. By com-
paring results between a sequence and its mutants,
the effects of mutation at a given position can be
determined. The knowledge gained can then be used
to guide the selection of positions and mutations in
future engineering efforts. In this case study, we use
ProtaBank’s “Identify and analyze sequence muta-
tions” tool to retrieve all the studies and assays con-
taining data for sequences closely related to wild-
type Gb1. After entering the sequence in the search
box, a BLAST search is performed to identify all
related mutant sequences. The BLAST search cur-
rently identifies 1.3 million sequences in Prota-
Bank that are closely related to wild-type Gb1.
Summary information is displayed in a mutant dis-
tribution heat map and a histogram showing the dis-
tribution of the number of mismatches (Fig. 4). The
heat map [Fig. 4(A)] shows the number of sequences
containing a mutation to a given amino acid at a
given position; the wild-type residue for each posi-
tion is shown in white. The heat map reveals that
the T2Q mutation (chartreuse) occurs most fre-
quently and that mutants at positions 39, 40, 41,
and 54 (yellow–green) represent a large number of
all the mutants identified. The T2Q mutation is
often included in studies of Gb1 to prevent cleavage
of the N-terminal methionine by post-processing
enzymes,36 and the preponderance of data for posi-
tions 39, 40, 41, and 54 is explained by a study that
examined all possible combinations of mutations at
these four positions, a total of 160,000 (204) var-
iants.37 The histogram [Fig. 4(B)] shows the number
of sequences found at each mismatch level, where
the number of mismatches is the number of muta-
tions needed to go from a given mutant sequence to
the search sequence. In this example, most of the
Table I. Assay Details Help Explain Differences in DGu Results for Wild-Type Gb1
Study Reference DGu (kcal/mol)
a Techniqueb T (8C)c pH
57 Choi and Mayo32 5.9d Thermal denaturation, circular dichroism 25 5.5
61 Gronenborn et al.29 5.6 GdmCl denaturation, fluorescence 25 5.4
72 Frank et al.30 4.1 Urea denaturation, fluorescence 25 2.0
74 Kuszewski et al.31 4.8 GdmCl denaturation, fluorescence 5 4.0
171 Davey et al.33 4.1 GdmCl denaturation, fluorescence 25 –e
a DGu, Gibbs free energy of unfolding.
b GdmCl, guanidinium chloride.
c T, temperature.
d Value was 25.9 for DG of folding; DGu is therefore opposite in sign (5.9).
e pH not reported.
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sequences are two or three mutations away from the
search sequence. These plots show information that
can help users determine which positions and muta-
tions have already been studied and which new ones
they might want to consider in future work.
An “Assays by property” table is also displayed
that lists all the assays containing data for a related
mutant sequence, grouped by the protein property
measured (Supporting Information Fig. S2). For
each property, the table lists all the individual
assays, number of unique sequences, and total num-
ber of data points. Links to each of the assays pro-
vide quick access to assay details. Each of the data
sets can be viewed via the # of data points link,
which opens up a table displaying the results for
that data set. This information can be downloaded
as a CSV or Excel file.
Case study 3: Determine the effects of
mutations on protein properties and compare
assay results
In this case study, we use additional features of Pro-
taBank’s “Identify and analyze sequence mutations”
tool to perform further analyses on the closely
related Gb1 sequences retrieved in Case study 2
above.
Plot one property versus another. For any two
measured properties, users can plot one property
versus another to show how these properties are
correlated. ProtaBank automatically performs the
unit conversions required to plot the data on the
same set of axes. In Figure 5, we compare two mea-
sures of stability: Tm and the denaturant
Figure 4. Identifying and analyzing closely related mutants of Gb1 in ProtaBank. (A) A BLAST search of the ProtaBank data-
base finds 1.3 million sequences that are closely related to wild-type Gb1. The heat map shows the frequency of each residue
at each position. The wild-type residue is shown in white. (B) Histogram showing the number of sequences found at each mis-
match level (Count), where the number of mismatches is the number of mutations needed to go from a given mutant sequence
to the search sequence.
Figure 5. Plots of Cm versus Tm for Gb1 data. A plot of all
Gb1 mutant sequences for which both a Tm and Cm were
measured (gray circles) gives a moderate correlation
(r5 0.45, dotted gray line). If we only include data obtained
under similar assay conditions (restricting Cm data to guanidi-
nium chloride denaturation, pH 5–7, 20–308C, and Tm data to
pH 5–7, no denaturant added) (blue triangles), a very strong
correlation (r5 0.80, blue line) between these two measures
of stability is observed.
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concentration at the midpoint of the unfolding transi-
tion (Cm) for all the closely related sequences of Gb1
retrieved in the BLAST search above (see Case study
2). A plot of all the Gb1 mutant sequences for which
both properties were measured (gray circles) shows a
moderate correlation (r5 0.45) between these two
properties, which could be explained by the fact that
this comparison does not take differences in assay
conditions into account. ProtaBank facilitates com-
parison of assay details by providing links to each of
the assays listed in the “Assays by property” table
(Supporting Information Fig. S2). If Tm versus Cm for
the Gb1 mutants is replotted using only data mea-
sured under similar assay conditions (e.g., pH, tem-
perature, and denaturant), a very strong correlation
is observed (r50.80) (Fig. 5, blue triangles).
Compare assay results. A recently published
study by Olson et al.38 used mRNA display and deep
mutational scanning to determine the fitness of all sin-
gle and double mutants of Gb1. The authors further
calculated a DDG predictor (DDGscreen), which used
their fitness values to predict the DG change in protein
stability upon single point mutations. The effectiveness
of the predictor was evaluated by comparing the pre-
dicted results to experimentally obtained DDGs
reported in the literature (DDGliterature). ProtaBank
provides a feature that allows this type of comparison
to be done quickly and easily. The “Compare assay to
others by mutation” feature allows all the input
mutants for one assay to be searched for and compared
to a given group of assays. ProtaBank automates the
time-consuming task of manually identifying relevant
literature results, converting the data to the same set
of units, and displaying pertinent assay and back-
ground sequence information. All the results can then
be further sorted and filtered by background sequence,
mutation, or study. We used this feature to reproduce
the comparison of DDGscreen to existing biochemical
measurements of DDG as shown in the Olson et al.
study.38 First, we did a “Compare assay to others by
mutation” on the closely related sequences of wild-type
Gb1; this search identified hundreds of mutant
sequence pairs in ProtaBank [Fig. 6(A)]. We then fil-
tered these results to the set of 10 background sequen-
ces and single point mutants listed in the Olson et al.
study [Fig. 6(B)]. Our filtered results match the data in
their paper exactly except for one point—the mutant
cited as I6L29 is actually a double mutant (I6L1T2Q)
and was therefore excluded in our single mutant
results. Note that ProtaBank identifies additional
mutations not included in the Olson et al. data set and
mutations with different background sequences (for a
total of 90 unique background sequences), expanding
the Olson et al. data set from 82 to 343 data points.
This feature makes it easy to compare the
results for the set of mutants in a given assay to
those from any other group of assays (the properties
measured can be the same or different). This allows
one to see if new assay data is consistent with previ-
ously observed trends. It can also be used to identify
protein properties that are well correlated with a
particular assay.
Case study 4: Visualize the relationship between
mutations and protein structure
Often PE data can be better understood in the con-
text of the protein’s 3D structure. In this case study,
Figure 6. Comparing predicted with experimentally measured DDG values in ProtaBank. ProtaBank search tools were used to
reproduce data from a study by Olson et al.38 in which Gb1 fitness values were used to predict the change in stability upon
point mutation. The DDG predictor values (DDGscreen) were plotted against experimental DDG values reported in the literature
(DDGliterature). (A) Unfiltered search of ProtaBank database identifies 343 mutant sequence pairs with both predicted and experi-
mental DDG values. (B) Search filtered by the mutations and background sequences from the Olson et al. study yields 82 pairs,
reproducing their data. Note that ProtaBank identifies 260 additional data points.
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we look at experimental data from the Olson et al.
Gb1 study described above38 by mapping the effect
of single mutations onto the crystal structure of the
protein. By visualizing the data in this way, trends
associated with structural features become more
obvious than when viewed in a table or chart.
In the Olson et al. study, fitness values for every
Gb1 point mutant were determined by generating a
DNA library encoding all single and double mutants
and assessing relative binding affinity to IgG Fc.
After a single round of affinity enrichment, the fit-
ness of each variant was determined by the change
in its frequency of occurrence (before vs. after
enrichment). We can view this data in 3D with the
protein visualizer, which is accessible via the study
analysis page. We could map the fitness data onto
the Gb1 backbone using the median deviation from
the wild-type value color scheme to help identify res-
idue positions that are sensitive to mutation, as we
did for the b-lactamase study in Figure 3(B). How-
ever, by just looking at the backbone image alone, it
may not be immediately apparent why some resi-
dues are more sensitive to mutation than others.
Further analysis and visualization capabilities
are therefore provided. ProtaBank allows you to
save the data values from the selected color scheme
in the occupancy column of the PDB file so that
other modeling or visualization software can be
used. In this case study, we used visual molecular
dynamics39 software to make the images shown in
Figure 7. Two views of Gb1 bound to the Fc domain
(PDB ID: 1FCC)40 are displayed. On the left, the
Gb1 backbone is colored by median deviation from
the wild-type value, with large deviations shown in
blue, medium in white, and small to no deviations in
red. On the right, the backbone is colored by proxim-
ity to the binding site: residues within 3.0 A˚ of the
Fc domain are shown in blue, those between 3.0 and
3.5 A˚ from the Fc domain are shown in white, and
those greater than 3.5 A˚ away are shown in red.
Note that most of the residues near the binding site
(right, blue or white) also show large median devia-
tions from the wild-type value (left, blue to white).
These results are understandable given that the
study employed a selection assay based on Fc bind-
ing. The structural analysis thus helps explain why
these residues are particularly sensitive to mutation
and suggests that the observed sensitivity is likely
due to disruption of the binding site rather than a
destabilization of the Gb1 fold.
Concluding Remarks and Future Development
ProtaBank offers an easily accessible cloud-based
modern database for PE data. It emphasizes the
specification of detailed assay information and full
protein sequences in an effort to ensure that all col-
lected data is not just stored, but that data from
diverse studies are comparable, searchable, and eas-
ily analyzed. ProtaBank has a convenient web inter-
face to facilitate data entry for single studies and a
REST API to allow for the upload of large data sets.
By accepting data submissions directly from
researchers, ProtaBank can incorporate the most
recent results and be managed with fewer resources.
Although this requires some effort on the part of the
individual researcher, ProtaBank offers many bene-
fits to submitters, including storing their data in an
organized format on the cloud and allowing results
to be searched and viewed by the scientific commu-
nity, thereby increasing its impact.
In future development, we will expand Prota-
Bank’s analysis and data mining tools. The current
analysis tools allow users to identify relevant data,
find correlations between types of data, create plots
and charts, and view results on the 3D structure.
We have also started more advanced integration
with protein structural data to allow for data selec-
tion and filtering on structural properties and to
allow for computational predictions based on struc-
tural and sequence information. Future tools include
incorporating computational methods to predict the
effect of mutations on protein properties such as sta-
bility, binding, and activity.
ProtaBank will provide a central location and
valuable entry point for researchers to store,
retrieve, compare, and analyze PE data. It will
make it easier for scientists to find previous results
to guide their designs and provide valuable data
sets that theoreticians can use as benchmarking
cases in developing better predictive algorithms. We
Figure 7. Comparing fitness and proximity to the binding site
for Gb1 point mutants. The ProtaBank visualizer was used to
map the Olson et al.38 fitness data to the Gb1 structure and
make the two images shown here. Gb1 (red, white, and blue)
is displayed bound to the Fc domain (gray) (PDB ID: 1FCC).40
On the left, the Gb1 backbone is colored by median deviation
from the wild-type value, going from blue to white to red,
with large deviations in blue, medium in white, and small to
no deviations in red. On the right, the backbone is colored by
proximity to the binding partner: blue if within 3.0 A˚ of the Fc
domain, white if between 3.0 and 3.5 A˚, and red if more than
3.5 A˚ away. The structural analysis shows that most of the
Gb1 residues near the binding interface are particularly sensi-
tive to mutation.
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expect that ProtaBank will serve a pivotal role in
centralizing PE data and leveraging the increasingly
large amount of mutational data being generated.
ProtaBank and its analysis tools will accelerate our
ability to understand sequence-function relation-
ships and greatly facilitate future protein design
and engineering efforts.
Supplementary Material
Supplementary material includes a table listing the
protein properties included in ProtaBank, a figure
showing a screenshot of the data entry page for a
mutant library, and a figure showing results
obtained from a sequence search.
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